Haleon plc has grown revenue 0.53% a year over three years and 2.2% a year over five, with earnings per share compounding at 17%. Revenue growth, 3-year annual rate: +0.53% (Drug Manufacturers - Specialty & Generic median +15%). Revenue growth, 5-year rate: +2.2%, growth has slowed since the five-year average. Earnings per share, 3-year rate: +17%, earnings outgrew revenue: margins or the share count worked for shareholders. Years of annual history on file: 6, FY2020 to FY2025, as filed.

HLNHaleon plc

HealthcareUSD

$10.19

$8.6152 weeks$11.12

Is it growing?

Is HLN growing?

Haleon plc has grown revenue 0.53% a year over three years and 2.2% a year over five, with earnings per share compounding at 17%.

+0.53%

Revenue growth, 3-year annual rate · Drug Manufacturers - Specialty & Generic median +15% · growing slowly · compounded from fiscal years as filed

Revenue growth, 5-year rate: +2.2%
Revenue growth, 5-year rate · +0.53% over three · growth has slowed since the five-year average
Earnings per share, 3-year rate: +17%
Earnings per share, 3-year rate · revenue +0.53% · earnings outgrew revenue: margins or the share count worked for shareholders
Years of annual history on file: 6
Years of annual history on file · FY2020 to FY2025, as filed